Insulet Corporation Rings the Closing Bell

ABOUT THIS EVENT

In recognition of National Diabetes Awareness Month and World Diabetes Day, Insulet Corporation (Nasdaq: PODD), virtually rings the closing bell at the Nasdaq Stock Market on Monday, November 15th.  Insulet Corporation is an innovative medical device company based in Acton, Massachusetts. It was founded in 2000 with the mission of improving the lives of people with diabetes. Shacey Petrovic, Director, President and Chief Executive Officer will be joined by members of the Insulet community who have made a significant contribution to the Company’s latest innovative product, the Omnipod 5® Automated Insulin Delivery System, including employees as well as clinical trial participants and health care providers. Omnipod 5 will be the first tubeless, automated insulin delivery system with compatible smartphone control in the U.S. The Omnipod 5 System received breakthrough device designation from the U.S. Food and Drug Administration and is currently under premarket review.